-
Covidien Reports Upbeat Q1 Earnings
Tuesday, February 1, 2011 - 7:31am | 56Covidien Plc (NYSE: COV) reports its Q1 adjusted EPS at $0.95, beating the consensus of $0.81. COV reports its Q1 revenue at $2.77 billion, versus the consensus of $2.73 billion. COV shares dropped 0.58% to $47.20 in after-hours trading. Read more from Benzinga's Company news.
-
Covidien Beats Estimates With $427 Million Profit (COV)
Tuesday, February 1, 2011 - 7:16am | 194Dublin, Ireland-based Covidien plc (NYSE: COV) announced on Tuesday morning that it beat consensus Wall Street estimates. Covidien plc reported that its 1st quarter net income rose 15.6% to $427 million, or 86 cents per share, up from $412 million, or 82 cents per share, a year earlier. Excluding...
-
Earnings Scheduled For February 1 (UPS, PFE, BIIB, ADM, COV, CE, MHP, LXK, BRCM, AFL, ERTS, BSX, WU)
Tuesday, February 1, 2011 - 4:20am | 337United Parcel Service Inc (NYSE: UPS) is expected to report its Q4 earnings at $1.05 per share on revenue of $13.41 billion. Pfizer (NYSE: PFE) is projected to report its Q4 EPS at $0.46 on revenue of $16.99 billion. Biogen Idec (NASDAQ: BIIB) is estimated to report its Q4 earnings at $1.23 per...
-
Hologic Losing Ground After Hours (HOLX)
Monday, January 31, 2011 - 5:18pm | 59Hologic (NASDAQ: HOLX) released its Q1 earnings results after the closing bell on Monday. The company reported non-GAAP EPS of $0.30 versus $0.29 in the year ago period. This compares to Wall Street consensus estimates of $0.28. Revenues were up 4.9% year over year. In the after hours trading...
-
Bard Reports Q4 EPS of $1.54 vs. $1.48
Monday, January 31, 2011 - 5:07pm | 184C. R. Bard, Inc. (NYSE: BCR) today reported 2010 fourth quarter financial results. Fourth quarter 2010 net sales were $717.1 million, an increase of 6 percent over the prior-year period. Excluding the impact of foreign exchange, fourth quarter 2010 net sales increased 7 percent over the prior-year...
-
Hologic Reports Q1 EPS of $.30 vs. $.30
Monday, January 31, 2011 - 5:02pm | 85Hologic, Inc. (Nasdaq: HOLX) today announced its results for the first fiscal quarter ended December 25, 2010. Revenues of $432.6 million. Net income was $10.9 million, or $0.04 per diluted share, calculated in accordance with U.S. generally accepted accounting principles (GAAP). Non-GAAP adjusted...
-
Earnings Preview: Boston Scientific - Analyst Blog
Monday, January 31, 2011 - 4:52pm | 943BostonScientific (BSX) is scheduled to release its fourth quarter and fiscal 2010 earnings on February 1, 2011 after the market close. The company is expected to report EPS of 10 cents on revenue of $1.989 billion for the quarter, and EPS of 38 cents on revenue of $7.794 million for the fiscal...
-
Earnings Preview: Boston Scientific - Analyst Blog
Monday, January 31, 2011 - 4:18pm | 943BostonScientific (BSX) is scheduled to release its fourth quarter and fiscal 2010 earnings on February 1, 2011 after the market close. The company is expected to report EPS of 10 cents on revenue of $1.989 billion for the quarter, and EPS of 38 cents on revenue of $7.794 million for the fiscal...
-
Earnings Scorecard: Stryker - Analyst Blog
Monday, January 31, 2011 - 4:01pm | 1234Orthopedic devices giant Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted (excluding one-time charges) earnings per share of 93 cents, above the Zacks Consensus Estimate of 90 cents. Highlights from the Quarter Profit (as reported) for...
-
Earnings Scorecard: Stryker - Analyst Blog
Monday, January 31, 2011 - 3:19pm | 1234Orthopedic devices giant Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted (excluding one-time charges) earnings per share of 93 cents, above the Zacks Consensus Estimate of 90 cents. Highlights from the Quarter Profit (as reported) for...
-
ABAX Misses EPS, Growth Sound - Analyst Blog
Monday, January 31, 2011 - 1:01pm | 510Abaxis Inc. (ABAX) reported third-quarter fiscal 2011 EPS of 17 cents, beating the year-ago quarter's 15 cents but missing Zacks Consensus Estimate by a penny. Net sales during the quarter increased 16% year over year to $35.9 million, in line with Zacks Consensus Estimate of $36 million. The...
-
ABAX Misses EPS, Growth Sound - Analyst Blog
Monday, January 31, 2011 - 12:30pm | 510Abaxis Inc. (ABAX) reported third-quarter fiscal 2011 EPS of 17 cents, beating the year-ago quarter's 15 cents but missing Zacks Consensus Estimate by a penny. Net sales during the quarter increased 16% year over year to $35.9 million, in line with Zacks Consensus Estimate of $36 million. The...
-
NASDAQ Stocks Hitting 52-Week Highs (CLDA, DEPO, CPSI, NPSP)
Monday, January 31, 2011 - 11:41am | 170Clinical Data Inc (NASDAQ: CLDA) shares gained 3.12% to create a new 52-week high of $28.22. CLDA shares have advanced 78.01% over the past 52 weeks, while the S&P 500 index has gained 18.85% in the same period. Depomed Inc (NASDAQ: DEPO) shares surged 30.45% to create a new 52-week high of $8....
-
Cardiac Posts Higher Loss - Analyst Blog
Monday, January 31, 2011 - 11:38am | 455Surgical devices maker Cardica Inc (CRDC) reported second-quarter fiscal 2011 (ended December 31) net loss per share of 13 cents, higher than the Zacks Consensus Estimate of a loss of 11 cents. Net loss swelled roughly 50% year over year to $3.3 million as higher costs offset an increase in the...
-
Cardiac Posts Higher Loss - Analyst Blog
Monday, January 31, 2011 - 11:15am | 455Surgical devices maker Cardica Inc (CRDC) reported second-quarter fiscal 2011 (ended December 31) net loss per share of 13 cents, higher than the Zacks Consensus Estimate of a loss of 11 cents. Net loss swelled roughly 50% year over year to $3.3 million as higher costs offset an increase in the...